CureVac N.V. (CVAC)
NASDAQ: CVAC · Real-Time Price · USD
5.12
0.00 (0.00%)
Dec 5, 2025, 4:00 PM EST - Market closed
CureVac Employees
As of December 31, 2024, CureVac had 983 total employees, including 825 full-time and 158 part-time employees. The number of employees decreased by 189 or -16.13% compared to the previous year.
Employees
983
Change (1Y)
-189
Growth (1Y)
-16.13%
Revenue / Employee
$84,436
Profits / Employee
$153,763
Market Cap
1.15B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CVAC News
- 2 days ago - BioNTech Achieves Minimum Condition in CureVac Exchange Offer - GlobeNewsWire
- 8 days ago - CureVac N.V. (CVAC) Shareholder/Analyst Call Prepared Remarks Transcript - Seeking Alpha
- 10 days ago - CureVac Announces Voting Results of Extraordinary General Meeting - Accesswire
- 12 days ago - CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2025 and Provides Business Updates - Accesswire
- 2 months ago - CureVac: The Hidden Value Of The mRNA Wallet - Seeking Alpha
- 4 months ago - CureVac Announces Financial Results for the Second Quarter and First Half of 2025 and Provides Business Updates - Accesswire
- 4 months ago - CureVac settles patent dispute litigation with Pfizer and BioNTech - Reuters
- 5 months ago - CureVac Announces Voting Results of General Meeting - Accesswire